| Dr Alan L Moore, MD | |
|
2000 Pepperell Pkwy, Opelika, AL 36801-5452 | |
| (334) 528-1112 | |
| (334) 528-1547 |
| Full Name | Dr Alan L Moore |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 34 Years |
| Location | 2000 Pepperell Pkwy, Opelika, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598721565 | NPI | - | NPPES |
| 510-79266 | Other | AL | BLUE CROSS OF AL PROV # |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207PE0004X | Emergency Medicine - Emergency Medical Services | 15874 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| East Alabama Medical Center And Snf | Opelika, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The East Alabama Health Care Authority | 3072403237 | 81 |
News Archive
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that the European Medicines Agency (EMA) has accepted the filing of the Marketing Authorization Application (MAA) for ADCETRIS for the treatment of relapsed or refractory Hodgkin lymphoma (HL) and relapsed or refractory systemic anaplastic large cell lymphoma.
A stranger began a chain of events that eventually saved the lives of six people in desperate need of new kidneys. Her organ donation triggered a six-way kidney swap at Houston Methodist Hospital in July, the second largest of its kind performed at one institution in Texas.
AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved LYNPARZA (olaparib) for use in patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have been previously treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting.
Since 2004, Claude Knauf (INSERM) and Patrice Cani (UCLouvain) have been collaborating on molecular and cellular mechanisms in order to understand the causes of the development of type 2 diabetes and above all to identify new therapeutic targets.
One of the largest studies of its kind has found that people with coronary artery disease who have even a modest beer belly or muffin top are at higher risk for death than people whose fat collects elsewhere. The effect was observed even in patients with a normal Body Mass Index.
› Verified 2 days ago
| Entity Name | The East Alabama Health Care Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073685483 PECOS PAC ID: 3072403237 Enrollment ID: O20040824001092 |
News Archive
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that the European Medicines Agency (EMA) has accepted the filing of the Marketing Authorization Application (MAA) for ADCETRIS for the treatment of relapsed or refractory Hodgkin lymphoma (HL) and relapsed or refractory systemic anaplastic large cell lymphoma.
A stranger began a chain of events that eventually saved the lives of six people in desperate need of new kidneys. Her organ donation triggered a six-way kidney swap at Houston Methodist Hospital in July, the second largest of its kind performed at one institution in Texas.
AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved LYNPARZA (olaparib) for use in patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have been previously treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting.
Since 2004, Claude Knauf (INSERM) and Patrice Cani (UCLouvain) have been collaborating on molecular and cellular mechanisms in order to understand the causes of the development of type 2 diabetes and above all to identify new therapeutic targets.
One of the largest studies of its kind has found that people with coronary artery disease who have even a modest beer belly or muffin top are at higher risk for death than people whose fat collects elsewhere. The effect was observed even in patients with a normal Body Mass Index.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alan L Moore, MD Po Box 4283, Opelika, AL 36803-4283 Ph: (334) 528-1112 | Dr Alan L Moore, MD 2000 Pepperell Pkwy, Opelika, AL 36801-5452 Ph: (334) 528-1112 |
News Archive
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that the European Medicines Agency (EMA) has accepted the filing of the Marketing Authorization Application (MAA) for ADCETRIS for the treatment of relapsed or refractory Hodgkin lymphoma (HL) and relapsed or refractory systemic anaplastic large cell lymphoma.
A stranger began a chain of events that eventually saved the lives of six people in desperate need of new kidneys. Her organ donation triggered a six-way kidney swap at Houston Methodist Hospital in July, the second largest of its kind performed at one institution in Texas.
AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved LYNPARZA (olaparib) for use in patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have been previously treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting.
Since 2004, Claude Knauf (INSERM) and Patrice Cani (UCLouvain) have been collaborating on molecular and cellular mechanisms in order to understand the causes of the development of type 2 diabetes and above all to identify new therapeutic targets.
One of the largest studies of its kind has found that people with coronary artery disease who have even a modest beer belly or muffin top are at higher risk for death than people whose fat collects elsewhere. The effect was observed even in patients with a normal Body Mass Index.
› Verified 2 days ago
Dr. Michael Nicholas Barbaree, D.O Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2000 Pepperell Pkwy, Opelika, AL 36801 Phone: 334-528-1112 Fax: 334-528-2161 | |
Chima Austin Ukachi, M.D Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3320 Skyway Dr Ste 807, Opelika, AL 36801 Phone: 334-539-1770 | |
Dr. Ricky L Ledkins, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2000 Pepperell Pkwy, Opelika, AL 36801 Phone: 334-528-1112 Fax: 334-528-1547 | |
Dr. Kim J Williams, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2000 Pepperell Pkwy, Opelika, AL 36801 Phone: 334-528-1112 Fax: 334-528-1547 | |
Zachary Smith, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2000 Pepperell Pkwy, Opelika, AL 36801 Phone: 334-528-4339 | |
Dr. James D Crosby, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2000 Pepperell Pkwy, Opelika, AL 36801 Phone: 334-528-1112 Fax: 334-528-1547 |